NCT00003289View on ClinicalTrials.gov

UCN-01 in Treating Patients With Advanced Cancer

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

June 30, 1998

Conditions
LeukemiaLymphomaUnspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

7-hydroxystaurosporine

Trial Locations (1)

21231

Johns Hopkins Oncology Center, Baltimore

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

OTHER

NCT00003289 - UCN-01 in Treating Patients With Advanced Cancer | Biotech Hunter | Biotech Hunter